Cancer.Net Associate Editor: Breast Cancer
Rogel Cancer Center, Ann Arbor, MI
Dr. Norah Lynn Henry is a Professor and Interim Chief of the University of Michigan's Division of Hematology/Oncology in the Department of Internal Medicine. She is the Breast Oncology Disease Lead at the Rogel Cancer Center. Dr. Henry specializes in the care of patients with all stages of breast cancer.
Dr. Henry’s research focuses on personalizing treatment for breast cancer. She studies treatments for breast cancer as well as ways to manage symptoms and side effects that arise from the cancer or its treatment. In addition, she works with scientists at the University of Michigan to translate their lab findings into clinical trials. She is also active in the National Cooperative Group SWOG (the Southwest Oncology Group), where she is Co-Chair of the Symptom Management and Quality of Life Committee, and in ASCO, where she serves on the Scientific Program Committee and the Conquer Cancer Foundation Grants Selection Committee, in addition to this role.
Before coming to the University of Michigan, Dr. Henry cared for patients and performed research in breast cancer and symptom management at the University of Utah.
View current ASCO disclosure here.
Last updated: September, 2022